Big Law
Tango Therapeutics To Sign $353 Million Merger Deal
Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special purpose acquisition company BCTG Acquisition worth up to a total of approximately $353m.
Approximately $167m is held in BCTG Acquisition’s trust account and a group of healthcare investors will take part in the deal through a common stock private investment in public equity of around $186m at $10 for each share.
The existing Tango shareholders are converting all their equity interests into common stock of the combined company.
